Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830550) titled 'Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development' on Sept. 15.
Study Type: Observational
Primary Sponsor: American Laboratory Products Company
Condition:
Healthy Volunteers
Syphilis Serologic Assay Development
Blood Specimen Collection
Diagnostic Assay Development
Serum Specimen Collection
Intervention:
Device: ALPCO Syphilis-T
Recruitment Status: Recruiting
Date of First Enrollment: October 2026
Target Sample Size: 50
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07830550
Published by HT Digital Content Services with permissio...